← Back to Syncom Formulations India Ltd Overview

📊Financials 📈PE Ratio 🥧Shareholding 💰Dividend 📋Quarterly ⚖️Balance Sheet 💹P&L 🌊Cash Flow

SYNCOMFPharmaceuticals

Syncom Formulations India Ltd — Financial Ratios & Key Metrics

₹10.30

-5.36%

P/E Ratio23.28xIndustry: 31.77x

ROE15.50%Return on equity

ROCE18.59%Return on capital

Debt/Equity0.00Debt free ✓

💎

Valuation & Profitability

P/E Ratio

23.28x

Industry Average P/E

31.77x

Dividend Yield

0.00%

Market Cap

₹1.46K (Cr)

Sales Growth 5Y

17.51%

Profit Growth 5Y

27.71%

EPS Growth 5Y

23.05%

OPM 5Y Avg

11.41%

📉

Price Returns

1 Month

-5.29%

3 Months

-7.98%

6 Months

-25.25%

1 Year

-22.58%

52W Low

₹11

Current

₹10

52W High

₹23

-5% of 52-week range — Near lows

🔬

Technical Indicators

Neutral

Momentum is balanced — neither overbought nor oversold.

SMA 50

₹13

▼ Price below SMA 50 — Bearish

SMA 200

₹16

▼ Long-term downtrend

Volume Signal

184% of avg

Above average volume — strong conviction behind price move

Technical indicators are for educational purposes only. Not investment advice.

More on Syncom Formulations India Ltd

Overview Financials PE History Shareholding Quarterly Balance Sheet P&L Cash Flow Pharmaceuticals Stocks Screener

Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.